Table 4.

The association of BDH1 mRNA expression, other clinical parameters, and liver cancer patient relapse-free survival.

	Univariate analysis			Multivariate analysis
Parameters	Hazard Ratio	95%CI (lower∼upper)	P value	Hazard Ratio	95%CI (lower-upper)	P value
Age	0.90	0.63–1.28	.550
Gender	0.99	0.7–1.41	.966
Histological type	2.02	0.66–6.24	.220
Histologic grade	0.98	0.8–1.21	.883
Stage	1.66	1.38–1.99	.000	1.11	0.87–1.43	.4
T classification	1.78	1.49–2.12	.000	1.58	1.21–2.05	.001
N Classification	0.97	0.67–1.4	.874
M classification	1.17	0.79–1.74	.432
Radiation therapy	0.74	0.26–2.16	.584
Residual tumor	1.28	1.01–1.61	.042	1.33	1.05–1.68	.02
BDH1	1.94	1.36–2.78	.003	1.55	1.07–2.24	.021